Status: current, Primitive. Date: 30-Jun 2014. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 118921000168110 | Oncotice BCG (trade product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 118931000168113 | Oncotice BCG | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Oncotice BCG | Is a | trade product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Oncotice BCG 500 million CFU powder for injection, 6 vials | has TP | True | Oncotice BCG | Inferred relationship | Some | |
| Oncotice BCG 500 million CFU powder for injection, 1 vial | has TP | True | Oncotice BCG | Inferred relationship | Some | |
| Oncotice BCG 500 million CFU powder for injection, 6 vials | has TP | True | Oncotice BCG | Inferred relationship | Some | |
| Oncotice BCG (Mycobacterium bovis (Bacillus Calmette and Guerin (BCG) Tice strain) 500 million CFU) powder for injection, 1 x 500 million CFU vial (containered trade product pack) | has TP | True | Oncotice BCG | Inferred relationship | Some | |
| Oncotice BCG 500 million CFU powder for injection, 3 vials | has TP | True | Oncotice BCG | Inferred relationship | Some | |
| Oncotice BCG 500 million CFU powder for injection, 500 million CFU vial | Is a | True | Oncotice BCG | Inferred relationship | Some | |
| Oncotice BCG 500 million CFU powder for injection, 3 vials | has TP | True | Oncotice BCG | Inferred relationship | Some |
Reference Sets
FHIR